% | $
Quotes you view appear here for quick access.

Pfizer Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • chlamydiapapiloma chlamydiapapiloma Aug 2, 2010 11:41 AM Flag

    Third day in the last four to see resistance in the low $15.40's

    50 dma is now leveling off in the 1480s. If PFE were to suffer a 3% drop like MRK on its earnings, the stock price could close back under the line.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • MRK was selling at a PE over ten - not just seven as in Pfizer's case.

      MRK also had just miserable results on Gardasil which had been so highly publicized just a few years ago. It suffered a pretty amazing 18% decline from a year ago.

      I can't imagine a big Pfizer drug doing that with there being a patent expiration involved.

      MRK also had to lower full-year estimates whereas PFE's numbers are always conservative enough where they don't have to do that. They already have that seven-cent beat from last quarter under their belt.

35.21+0.20(+0.57%)Jun 30 4:01 PMEDT